BIOXYDYN LIMITED
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10- Legal registered address
- St James Tower 7 Charlotte Street Manchester England M1 4DZ Copied!
Latest financial results as of 20 August 2025- Cash in bank
- £47.97k
- Current assets
- £257.81k
- Fixed assets
- £1.00m
- Current creditors
- £354.93k
- Shareholders funds
- £3.24m
View full financial accounts- Cash in bank
- £47.97k
- Current assets
- £257.81k
- Fixed assets
- £1.00m
- Current creditors
- £354.93k
- Shareholders funds
- £3.24m
- Company number
- 06838431 Copied!
Accounts
Latest annual accounts were to 30 November 2023
Next annual accounts are due by 31 August 2025
Company financial year end is on 30 November 2025
Confirmation statement
Latest confirmation statement statement dated 7 September 2023
Next statement due by 21 September 2024
Nature of business (SIC)
72110 - Research and experimental development on biotechnology
Latest company documents
| Date | Description |
|---|---|
| 06/11/246 November 2024 | Confirmation statement made on 2024-09-07 with no updates |
| 10/08/2410 August 2024 | Total exemption full accounts made up to 2023-11-30 |
| 08/01/248 January 2024 | Director's details changed for Mr Matthew James Heaton on 2024-01-02 |
| 30/11/2330 November 2023 | Annual accounts for year ending 30 Nov 2023 |
| 03/11/233 November 2023 | Confirmation statement made on 2023-09-07 with no updates |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company